Bank of New York Mellon Corp - SYROS PHARMACEUTICALS INC ownership

SYROS PHARMACEUTICALS INC's ticker is SYRS and the CUSIP is 87184Q107. A total of 68 filers reported holding SYROS PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of SYROS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2022$25,000
-89.0%
26,447
-86.1%
0.00%
Q1 2022$227,000
-64.1%
190,319
-1.9%
0.00%
Q4 2021$633,000
-27.7%
194,045
-1.1%
0.00%
Q3 2021$876,000
-13.9%
196,145
+5.0%
0.00%
Q2 2021$1,018,000
-7.6%
186,846
+26.8%
0.00%
Q1 2021$1,102,000
-25.4%
147,357
+8.2%
0.00%
Q4 2020$1,477,000
+16.0%
136,141
-5.5%
0.00%
Q3 2020$1,273,000
-19.9%
144,089
-3.3%
0.00%
Q2 2020$1,589,000
+129.6%
149,048
+27.6%
0.00%
Q1 2020$692,000
-10.1%
116,764
+4.8%
0.00%
Q4 2019$770,000
-33.4%
111,363
-0.1%
0.00%
Q3 2019$1,157,000
+17.9%
111,465
+5.2%
0.00%
Q2 2019$981,000
+28.9%
105,908
+27.2%
0.00%
Q1 2019$761,000
+61.9%
83,250
-1.5%
0.00%
Q4 2018$470,000
-49.2%
84,537
+8.9%
0.00%
Q3 2018$925,000
+28.5%
77,654
+10.0%
0.00%
Q2 2018$720,000
+7.5%
70,592
+36.8%
0.00%
Q1 2018$670,000
+95.3%
51,587
+46.5%
0.00%
Q4 2017$343,000
-34.0%
35,219
-0.3%
0.00%
Q3 2017$520,000
+7.7%
35,329
+17.7%
0.00%
Q2 2017$483,000
+161.1%
30,024
+157.9%
0.00%
Q1 2017$185,00011,6420.00%
Other shareholders
SYROS PHARMACEUTICALS INC shareholders Q2 2019
NameSharesValueWeighting ↓
Samsara BioCapital, LLC 1,726,603$15,228,00010.06%
Flagship Pioneering Inc. 3,204,437$29,673,0001.28%
Redmile Group, LLC 3,620,376$33,525,0000.95%
ARK Investment Management 3,791,756$35,112,0000.88%
Nikko Asset Management Americas, Inc. 2,987,763$27,667,0000.54%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,268,946$11,750,0000.42%
683 Capital Management, LLC 429,775$3,980,0000.36%
EcoR1 Capital, LLC 248,480$2,301,0000.23%
ALGERT GLOBAL LLC 17,920$166,0000.06%
Baker Brothers Advisors 974,835$9,027,0000.06%
View complete list of SYROS PHARMACEUTICALS INC shareholders